• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非药物干预预防首发精神分裂症或双相情感障碍患者体重增加的效果:系统评价。

Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.

机构信息

Aarhus University Hospital, Psychiatry, Department of Depression and Anxiety, Denmark.

Aarhus University Hospital, Psychiatry, Department of Child and Adolescent Psychiatry, Denmark.

出版信息

Psychiatry Res. 2019 Nov;281:112556. doi: 10.1016/j.psychres.2019.112556. Epub 2019 Sep 4.

DOI:10.1016/j.psychres.2019.112556
PMID:31521840
Abstract

Weight gain is a side effect of antipsychotic medication and highly prevalent in people with schizophrenia or bipolar disorder, increasing their overall cardio-metabolic risk. We conducted a systematic review on non-pharmacological interventions for preventing/reducing weight gain or increase in waist-circumference in young, newly diagnosed patients with schizophrenia or bipolar disorder. We searched major electronic databases from inception to 04/2019 on RCTs, pre- and post-test studies, and non-randomized controlled clinical trials. From a potential of 2963 hits, eight studies met the inclusion criteria (n = 438, mean age of 18.8 (13-45) years). The interventions comprised supervised and individually adjusted aerobic exercise activities (5 studies), individual lifestyle counselling vs. control condition (2 RCTs), and dietetic counselling and practical training of cooking and shopping (1 study). Physical activity and practical dietetic interventions seem to be more efficient than lifestyle counselling. However, the results shall be taken with caution due to the non-randomized designs and other methodologically deficits in the majority of the included studies.

摘要

体重增加是抗精神病药物的副作用,在精神分裂症或双相情感障碍患者中非常普遍,增加了他们整体心血管代谢风险。我们对预防/减少年轻、新诊断的精神分裂症或双相情感障碍患者体重增加或腰围增加的非药物干预措施进行了系统评价。我们从主要的电子数据库中搜索了从成立到 2019 年 4 月的 RCT、预测试和非随机对照临床试验。在 2963 个潜在结果中,有 8 项研究符合纳入标准(n=438,平均年龄 18.8(13-45)岁)。干预措施包括监督和个体化调整的有氧运动活动(5 项研究)、个体生活方式咨询与对照组(2 项 RCT)、饮食咨询和烹饪与购物实践培训(1 项研究)。与生活方式咨询相比,体育活动和实用饮食干预似乎更有效。然而,由于大多数纳入研究的非随机设计和其他方法学缺陷,结果应谨慎对待。

相似文献

1
Non-pharmacological interventions for preventing weight gain in patients with first episode schizophrenia or bipolar disorder: A systematic review.非药物干预预防首发精神分裂症或双相情感障碍患者体重增加的效果:系统评价。
Psychiatry Res. 2019 Nov;281:112556. doi: 10.1016/j.psychres.2019.112556. Epub 2019 Sep 4.
2
[Non-Pharmacological Interventions for the Prevention of Weight Gain in Schizophrenic Patients Treated with Antipsychotic Medication].
Psychiatr Prax. 2015 Oct;42(7):359-69. doi: 10.1055/s-0035-1552670. Epub 2015 Jul 9.
3
Body weight and metabolic adverse effects of asenapine, iloperidone, lurasidone and paliperidone in the treatment of schizophrenia and bipolar disorder: a systematic review and exploratory meta-analysis.在精神分裂症和双相情感障碍的治疗中,阿塞那平、依匹哌酮、鲁拉西酮和帕利哌酮的体重和代谢不良影响:系统评价和探索性荟萃分析。
CNS Drugs. 2012 Sep 1;26(9):733-59. doi: 10.2165/11634500-000000000-00000.
4
Metformin for olanzapine-induced weight gain: a systematic review and meta-analysis.二甲双胍治疗奥氮平所致体重增加:系统评价和荟萃分析。
Br J Clin Pharmacol. 2011 Mar;71(3):377-82. doi: 10.1111/j.1365-2125.2010.03783.x.
5
Improvements in metabolic abnormalities among overweight schizophrenia and bipolar disorder patients.超重的精神分裂症和双相情感障碍患者代谢异常情况的改善。
Eur Psychiatry. 2014 Sep;29(7):402-7. doi: 10.1016/j.eurpsy.2013.11.005. Epub 2014 Jan 16.
6
Lifestyle intervention and metformin for treatment of antipsychotic-induced weight gain: a randomized controlled trial.生活方式干预与二甲双胍治疗抗精神病药物所致体重增加:一项随机对照试验。
JAMA. 2008 Jan 9;299(2):185-93. doi: 10.1001/jama.2007.56-b.
7
Exercise, diet and educational interventions for metabolic syndrome in persons with schizophrenia: A systematic review.锻炼、饮食和教育干预对精神分裂症患者代谢综合征的影响:系统评价。
Asian J Psychiatr. 2018 Aug;36:73-85. doi: 10.1016/j.ajp.2018.06.018. Epub 2018 Jun 30.
8
[Metabolic side effects of risperidone in early onset schizophrenia].[利培酮在早发性精神分裂症中的代谢副作用]
Encephale. 2010 Jun;36(3):242-52. doi: 10.1016/j.encep.2009.10.008. Epub 2009 Dec 1.
9
Subjective Versus Objective Weight Gain During Acute Treatment With Second-Generation Antipsychotics in Schizophrenia and Bipolar Disorder.精神分裂症和双相情感障碍患者在第二代抗精神病药物急性治疗期间主观与客观体重增加情况
J Clin Psychopharmacol. 2016 Dec;36(6):637-642. doi: 10.1097/JCP.0000000000000596.
10
Schizophrenia and weight management: a systematic review of interventions to control weight.精神分裂症与体重管理:控制体重干预措施的系统评价
Acta Psychiatr Scand. 2003 Nov;108(5):324-32. doi: 10.1034/j.1600-0447.2003.00218.x.

引用本文的文献

1
Clinical outcomes and anti-inflammatory mechanisms predict maximum heart rate improvement after physical activity training in individuals with psychiatric disorders and comorbid obesity.临床结局和抗炎机制可预测精神疾病合并肥胖个体进行体育活动训练后最大心率的改善情况。
PLoS One. 2025 Jan 3;20(1):e0313759. doi: 10.1371/journal.pone.0313759. eCollection 2025.
2
Exercise and Schizophrenia.锻炼与精神分裂症。
Curr Top Behav Neurosci. 2024;67:367-379. doi: 10.1007/7854_2024_505.
3
Diet and physical activity and metabolic disorders in patients with schizophrenia and bipolar affective disorder in the Polish population.
波兰人群中精神分裂症和双相情感障碍患者的饮食和身体活动与代谢紊乱。
PeerJ. 2023 Jul 11;11:e15617. doi: 10.7717/peerj.15617. eCollection 2023.
4
Recruitment, attrition and intervention completion in clinical trials of psychosocial interventions involving people with early and emerging psychosis: a systematic review protocol.涉及早期和初发精神病患者的心理社会干预临床试验中的招募、脱落和干预完成情况:系统评价方案。
BMJ Open. 2022 Sep 7;12(9):e060863. doi: 10.1136/bmjopen-2022-060863.
5
Effectiveness of dietary interventions in mental health treatment: A rapid review of reviews.饮食干预对心理健康治疗的有效性:综述的快速回顾。
Nutr Diet. 2022 Jul;79(3):279-290. doi: 10.1111/1747-0080.12754.
6
Aripiprazole and Risperidone Present Comparable Long-Term Metabolic Profiles: Data From a Pragmatic Randomized Controlled Trial in Drug-Naïve First-Episode Psychosis.阿立哌唑和利培酮呈现出相当的长期代谢特征:来自一项药物初发精神分裂症患者的实用随机对照试验的数据。
Int J Neuropsychopharmacol. 2022 Oct 25;25(10):795-806. doi: 10.1093/ijnp/pyac033.
7
Probiotics Plus Dietary Fiber Supplements Attenuate Olanzapine-Induced Weight Gain in Drug-Naïve First-Episode Schizophrenia Patients: Two Randomized Clinical Trials.益生菌联合膳食纤维补充剂可减轻未经药物治疗的首发精神分裂症患者奥氮平引起的体重增加:两项随机临床试验。
Schizophr Bull. 2022 Jun 21;48(4):850-859. doi: 10.1093/schbul/sbac044.
8
REalist Synthesis Of non-pharmacologicaL interVEntions for antipsychotic-induced weight gain (RESOLVE) in people living with severe mental illness (SMI).针对严重精神疾病(SMI)患者抗精神病药引起的体重增加的非药物干预措施的真实世界综合研究(RESOLVE)。
Syst Rev. 2022 Mar 9;11(1):42. doi: 10.1186/s13643-022-01912-9.
9
The Effect of Yijinjing on the Cognitive Function of Patients With Chronic Schizophrenia.易筋经对慢性精神分裂症患者认知功能的影响
Front Psychiatry. 2021 Oct 20;12:739364. doi: 10.3389/fpsyt.2021.739364. eCollection 2021.